---
$id: https://graph.org.ai/products/commodity/51162620
$type: Product
source: UNSPSC
code: "51162620"
title: "Dimethoxanate"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dimethoxanate

**UNSPSC Code**: 51162620
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular formula C19H22N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 1E3KG5FWDB, chemically known as 10h-phenothiazine-10-carboxylic acid, 2-(2-(dimethylamino)ethoxy)ethyl ester but more generally known as dimethoxanate, which bears US NIH Compound Identifier 10610. European Medicines Agency schedules Dimethoxanate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07175MIG. The term DIMETHOXANATE is an International Non-Proprietary Name. World Health Organization schedules dimethoxanate in its Anatomical Therapeutic Chemical (ATC) Classification. DIMETHOXANATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule dimethoxanate under HS 29343090 and SITC 51578. As of Q4 2014, DIMETHOXANATE remains US FDA's Preferred Term for this commodity. Dimethoxanate bears US NLM identifiers UMLS ID C0392426 and NCI Concept Code C80896. SMILES: S1C2C(N(C3C1CCCC3)C(=O)OCCOCCN(C)C)CCCC2.

